HEM Pharma Inc
KOSDAQ:376270
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
HEM Pharma Inc
KOSDAQ:376270
|
KR |
|
F
|
Firstfarms A/S
CSE:FFARMS
|
DK |
|
P
|
Purple Beverage Company Inc
OTC:PPBV
|
US |
|
C
|
Cosmax NBT Inc
KOSDAQ:222040
|
KR |
|
H
|
Hana Micron Inc
KOSDAQ:067310
|
KR |
|
Landis+Gyr Group AG
F:4LG
|
CH |
|
N
|
Nomura Research Institute Ltd
XMUN:NR7
|
JP |
|
Toyota Motor Corp
F:TOM
|
JP |
|
Fuelcell Energy Inc
F:FEY
|
US |
|
Cadence Design Systems Inc
NASDAQ:CDNS
|
US |
|
N
|
New Hope Corporation Ltd
F:OD8
|
AU |
|
CNNC Hua Yuan Titanium Dioxide Co Ltd
SZSE:002145
|
CN |
|
N
|
NXP Semiconductors NV
SWB:VNX
|
NL |
Bankruptcy Probability
HEM Pharma Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Financial Position
| Jun 30, 2026 | 9.6B |
| Mar 31, 2026 | 12.5B |
| Dec 31, 2025 | 5.3B |
| Sep 30, 2025 | 5.3B |
| Jun 30, 2026 | 1.6B |
| Mar 31, 2026 | 1.5B |
| Dec 31, 2025 | 273.5m |
| Sep 30, 2025 | 273.5m |
| Jun 30, 2026 | 12.1B |
| Mar 31, 2026 | 12.5B |
| Dec 31, 2025 | 11.9B |
| Sep 30, 2025 | 11.9B |
Solvency Ratios
Solvency Ratios Comparison
HEM Pharma Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
H
|
HEM Pharma Inc
KOSDAQ:376270
|
183.6B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
505.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
249.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
207.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
134.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
103.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
91.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
55.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
41.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
HEM Pharma Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, HEM Pharma Inc has total debt of 12.1B KRW. This includes both short-term (7.4B KRW) and long-term (4.7B KRW) debt.
You can find a full breakdown on its Balance Sheet.